Mr James Cooper & Ali Gibson

Stoke Mandeville Spinal Research (SMSR)

James manages the PReSUTINeB study at Stoke Mandeville Hospital. Before that James worked within research governance at Oxford University Hospitals NHS Foundation Trust for over six years.

Ali sustained a spinal cord injury in 1996. She went on to study at the University of Nottingham and graduated in 2006 with a first class honours in Psychology.
Ali is passionate about peer support and maximizing the outcomes of rehabilitation following spinal cord injury and other long-term neurological conditions. She has proven experience of academic and clinical research, clinical trial management, peer support, mentoring and public speaking.
Having first-hand experience of living with the impact of spinal cord injury, Ali is committed to supporting research that aims to improve people’s quality of life following spinal cord injury. In her current position as Community Liaison Officer for Stoke Mandeville Spinal Research (SMSR), she works closely with key stakeholders and in the community to raise awareness of living with spinal cord injury and to discuss the research that that is being undertaken by SMSR.

dont miss

Investigating UTI prevention using Immunotherapy- update on the PReSUTINeB study

The PReSUTINeB study is a double blinded, placebo controlled study assessing if an immunotherapy treatment, in the form of an oral capsule, can reduce the incidence of symptomatic urinary tract infections in patients with spinal cord injury, multiple sclerosis, transverse myelitis and cauda equina syndrome. The intervention started in March 2018.

The seminar will also include a short talk from the SMSR Community Liaison Officer Ali Gibson who will discuss her first-hand experience with symptomatic urinary tract infections and how this impacts her quality of life.

EVEN MORE SEMINARS

  • Neelam Kaur: Speaking at the European Neurological Convention

    Neelam Kaur
    Premium Care Solutions

    Complex Care at Home: The good, the bad and the extraordinary

  • Heather Campbell: Speaking at the European Neurological Convention

    Heather Campbell
    Guys & St Thomas’ NHS Foundation trust

    Navigating pathways for “invisible patients” in South East London

  • Andrew Fahey: Speaking at the European Neurological Convention

    Andrew Fahey
    Brookson Direct

    The Impact of IR35 on the NHS

  • Dr. Salim Ghoussayni: Speaking at the European Neurological Convention

    Dr. Salim Ghoussayni
    MindMaze SA

    The role of virtual reality technologies in neurorehabilitation

  • Prof Xavier Golay: Speaking at the European Neurological Convention

    Prof Xavier Golay
    Gold Standard Phantoms Limited

    Reference standards for establishment of quantitative imaging biomarkers in neurology